Somatuline Autogel Preference and Health Economy Study
- 18 décembre 2024 - 1 mn de lecture
The primary aim of this study is to assess which method of lanreotide Autogel administration patients with neuroendocrine tumours prefer – self/partner administrations or healthcare provided administrations. The study will also assess if self/partner administration can be performed without loss of efficacy and with a preserved safety profile. The impact of self/partner administration on resource utilisation and costs will be studied. In addition, we will also assess the healthcare provider’s experience of the two administration practices.
18 décembre 2024
1 mn de lecture
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
18 décembre 2024
1 mn de lecture
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
18 décembre 2024
1 mn de lecture
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
18 décembre 2024
1 mn de lecture
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
18 décembre 2024
1 mn de lecture
Dysport® Adult Lower Limb Spasticity Follow-on Study
18 décembre 2024
1 mn de lecture
Dysport® Pediatric Lower Limb Spasticity Study
18 décembre 2024
1 mn de lecture
Dysport® Adult Lower Limb Spasticity Study
18 décembre 2024
1 mn de lecture
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
18 décembre 2024
1 mn de lecture
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
18 décembre 2024
1 mn de lecture